Marshall Fordyce
Fortune : 13 M $ au 31/05/2026
Fortune : 13 M $ au 31/05/2026
Marshall W.
Fordyce is the founder of Vera Therapeutics, Inc., founded in 2016, serving as President, Chief Executive Officer & Director.
The current job is Non-Executive Director at Albert & Mary Lasker Foundation since 2012.
Former job includes Senior Director-Clinical Research at Gilead Sciences, Inc. from 2011 to 2016.
Education includes undergraduate degree from Harvard University and doctorate from Harvard Medical School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/07/2026 | 374 024 ( 0,52 % ) | 13 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VERA THERAPEUTICS, INC. | Fondateur | 01/05/2016 |
Albert & Mary Lasker Foundation
Albert & Mary Lasker Foundation The Albert & Mary Lasker Foundation is a company based in New York, NY. | Directeur/Membre du Conseil | 01/04/2012 |
| Sociétés | Poste | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/07/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert & Mary Lasker Foundation
Albert & Mary Lasker Foundation The Albert & Mary Lasker Foundation is a company based in New York, NY. | |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national